Thrombopoietin mimetics

Details Thrombopoietin mimetics Thrombopoietin mimetics

2007-01-08

2008-10-21

Powers, Fiona T (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Azo

C534S775000, C534S792000

Reexamination Certificate

active

07439342

ABSTRACT:
Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

REFERENCES:
patent: 851444 (1907-04-01), Shulthess
patent: 2809963 (1957-10-01), Hanhart
patent: 2950273 (1960-08-01), Pelz
patent: 3366619 (1968-01-01), DeLucia
patent: 4435417 (1984-03-01), Toja et al.
patent: 4510149 (1985-04-01), Cozzi et al.
patent: 4686285 (1987-08-01), Pedrazzi
patent: 4880788 (1989-11-01), Moake et al.
patent: 4948900 (1990-08-01), Iijima et al.
patent: 5326776 (1994-07-01), Winn et al.
patent: 5482546 (1996-01-01), Eida et al.
patent: 5532202 (1996-07-01), Yoshida
patent: 5622818 (1997-04-01), Kapp et al.
patent: 5669967 (1997-09-01), Hays
patent: 5746821 (1998-05-01), Hays
patent: 5760038 (1998-06-01), Murugesan et al.
patent: 5932546 (1999-08-01), Barrett et al.
patent: 6214813 (2001-04-01), Zhang et al.
patent: 6238442 (2001-05-01), Schumacher et al.
patent: 6248871 (2001-06-01), Ebenezer et al.
patent: 6280959 (2001-08-01), Gleason et al.
patent: 6436915 (2002-08-01), Zhang et al.
patent: 6608077 (2003-08-01), Widdowson et al.
patent: 7160870 (2007-01-01), Duffy et al.
patent: 2003/0060453 (2003-03-01), Zhang et al.
patent: 2004/0063764 (2004-04-01), Takemoto et al.
patent: 2004/0082626 (2004-04-01), Takemoto et al.
patent: 2005/0054643 (2005-03-01), South et al.
patent: 193350 (1907-12-01), None
patent: 1046220 (1958-12-01), None
patent: 0 638 617 (1994-04-01), None
patent: 1 207 155 (2000-07-01), None
patent: 1 253 142 (2001-01-01), None
patent: 1 104 674 (2001-06-01), None
patent: 826207 (1956-07-01), None
patent: 779 880 (1957-07-01), None
patent: 2002-371213 (2002-12-01), None
patent: WO 93/17681 (1993-09-01), None
patent: WO 94/26709 (1994-11-01), None
patent: WO 96/40750 (1996-12-01), None
patent: WO 98/46606 (1998-10-01), None
patent: WO 99/15500 (1999-01-01), None
patent: WO 99/11262 (1999-11-01), None
patent: WO 00/35446 (2000-06-01), None
patent: WO 01/07423 (2001-01-01), None
patent: WO 01/77080 (2001-01-01), None
patent: WO 01/17349 (2001-03-01), None
patent: WO 01/21180 (2001-03-01), None
patent: WO 01/34585 (2001-05-01), None
patent: WO 02/59099 (2002-01-01), None
patent: WO 02/59100 (2002-01-01), None
patent: WO 02/49413 (2002-06-01), None
patent: WO 02/057300 (2002-07-01), None
patent: WO 02/085343 (2002-10-01), None
patent: WO 03/045379 (2003-05-01), None
patent: WO03/074550 (2003-09-01), None
patent: WO03/098992 (2003-12-01), None
patent: WO 03/103686 (2003-12-01), None
patent: WO 2004/054515 (2004-07-01), None
patent: WO 2004/096154 (2004-11-01), None
patent: WO 2005/041867 (2005-12-01), None
Yamazaki, et al., Database HCAPLUS, AN 1995: Abstract, 196968.
A. Esteve, Ann. Pharm. Franc., 1950, vol. 8, No. 9-10, pp. 594-604.
Morris, et al., Anti-Cancer Drugs, 1997, vol. 8, No. 8, pp. 746-755.
Duffy, et al., J. Med. Chem., 2001, vol. 44, No. 22, Abstract No. XP002197261.
Bartley, et al., Cell, 1994, vol. 77, pp. 1117-1124.
Olszewski, et al., Database CAPLUS on STN, 1995, Chem. Abstracts, No. 122:81695.
Olszewski, et al., J. Org. Chem., 1994, vol. 59, pp. 4285-4296.
Lamb, et al., Nucleic Acids Research, 1995, vol. 23, No. 16, pp. 3283-3289.
Seidel, et al., Proc. Natl. Acad. Sci. USA, Mar. 1995, vol. 92, pp. 3041-3045.
Berkhout, et al., J. of Biological Chemistry, Jun. 1997, vol. 272, No. 26, pp. 16404-16413.
Vermeulen, et al., Blood, 1998, vol. 92, No. 3, pp. 894-900.
Hasegawa, et al., Int. J. Immunopharmac, 1996, vol. 18, No. 2, pp. 103-112.
Kumamoto, et al., British Journal of Haematology, 1999, vol. 105, pp. 1025-1033.
Shiotsu, et al., Experimental Hematology, 1998, vol. 26, pp. 1195-1201.
Komatsu, et al., Blood, 1996, vol. 87, No. 11, pp. 4552-4560.
Uguccioni, et al., J. Exp. Med., 1996, vol. 183, pp. 2397-2384.
Taylor, et al., J. Org. Chem., 1987, vol. 52, pp. 4107-4110.
Kuter, et al., Seminars in Hematology, Apr. 2000, vol. 37, No. 2, pp. 41-49.
Ballestrero, et al., Oncology, 2000, vol. 59, pp. 7-13.
Sawai, et al., Journal of Leukocyte Biology, Jul. 2000, vol. 68, pp. 137-143.
Vigon, et al., Proc. Natl. Acad. Sci. USA, Jun. 1992, vol. 89, pp. 5640-5644.
Laurenz, et al., Comp. Biochem Physiol., 1997, vol. 116A, No. 4, pp. 369-377.
Metcalf, et al., Nature, Jun. 16, 1994, vol. 369, pp. 519-520.
Bussel, et al., Seminars in Hematology, 2000, vol. 37, pp. 1-49 (Table of Contents).
McDonald, et al., Am. J. of Pediatric Hematology/Oncology, 1992, vol. 14, No. 1, pp. 8-21.
Souyri, et al., Cell, 1990, vol. 63, pp. 1137-1147.
Bazan, et al., Pro. Natl. Acad. Sci. USA, Sep. 1990, vol. 87, pp. 6934-6938.
Sauvage, et al., Nature, Jun. 16, 1994, vol. 369, pp. 533-538.
Wendling, et al., Nature, Jun. 16, 1994, vol. 369, pp. 571-574.
Kaushansky, et al., Nature, Jun. 16, 1994, vol. 369, pp. 568-571.
King, et al., The Journal of Immunology, 2000, pp. 3774-3782.
Kikuta, et al., Experimental Hematology, 2000, vol. 28, pp. 311-317.
Somlo, et al., Blood, May 1, 1992, vol. 93, No. 9, pp. 2798-2806.
Kirley-Neumann, et al., Cytokines, Cellular & Molecular Therapy, 2000, vol. 6, pp. 47-56.
Egger, et al., Bone Marrow Transplant, 1998, vol. 22, pp. 34-35.
Gaudron, et al., Stem Cells, 1999, vol. 17, pp. 100-106.
Fetscher, et al., Current Opinion in Hematology, 2000, vol. 7, pp. 255-260.
Clemons, et al., Breast Cancer Res. Treatment, 1999, vol. 57, p. 127.
Greene, “Protective Groups in Organic Synthesis”, 1981, Table of Contents.
Methia, et al., Blood, 1993, vol. 82, No. 5, pp. 1395-1401.
Yamazaki, et al., Japn. J. Toxicol. Environ. Health, 1994, vol. 94, No. 5, pp. 448-453.
Duffin, et al., J. of the Chem. Soc., 1954, pp. 408-441.
King, et al., Scand. J. of Immunol., 1999, vol. 49, No. 2, pp. 184-192.
Konica Corp. Derwent No. 92-077508/10, 1992.
Mitsubishi Pharma Corp. Derwent No. 2003-845201/78, 2003.
Mitsubishi Pharma Corp. Derwent No. 2003-767492/72, 2003.
Balli, et al., Dyes. Pigm., 1981, vol. 2, No. 2, pp. 93-124.
Balli, et al., Justus Liebigs Ann. Chem., 1966, vol. 699, pp. 133-134.
Dziomko, et al., Chem. Heterocycl. Compd., 1984, vol. 20, No. 2, pp. 196-200.
Duffy, et al., J. Med. Chem., 2001, vol. 44, No. 22, p. 3730-3745.
Kimura, et al., FEBS Letters, 1998, vol. 428, No. 3, pp. 250-254.
Beckert, et al., Monatshefte Fur Chemie, 1989, vol. 120, pp. 1125-1137.
A. Esteve, Ann. Pharm. Franc., 1950, vol. 8, No. 9-10.
PCT/US2004/13468 filed Apr. 29, 2004—(WO 04/096154).
PCT/US2004/034944 filed Oct. 21, 2004—(WO 05/041867).
Minssen-Guette, et al., Bulletin De La Societe Chimique De France, 1986, No. 5, pp. 2106-2110.
European Search report dated Dec. 15, 2003.
European office action dated Feb. 2, 2005.
Bussel, et al., Seminars in Hematology, 2000, vol. 37, pp. 1-49 (whole journal). see ids #7.
Balli, et al., Dyes. Pigm., 1981, vol. 2, No. 2, pp. 93-124 (sent original).
Balli, et al., Justus Liebigs Ann. Chem., 1966, vol. 699, pp. 133-144. (sent original).
USPTO Office action dated Feb. 22, 2006, (6 pages).
Response to US OA dated Aug. 7, 2006, (15 pages).
Nagarajan, et al. Proc. Indian Acad. Sci., 1977, vol. 86A, No. 1, pp. 25-39.

Affiliated with

Also associated with

Rating

Thrombopoietin mimetics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thrombopoietin mimetics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombopoietin mimetics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4015981